Effects of Alchemilla vulgaris and glycerine on epithelial and myofibroblast cell growth and cutaneous lesion healing in rats

Phytotherapy Research

Volumn 21, Issue 4, 2007, Pages 369-373

  Shrivastava, Ravi ^a   Cucuat, Nathalie ^a   John, Gareth W ^a  

^a ZAC de Lavaur   (France)

Author keywords

Alchemilla vulgaris; Glycerine; Proliferation; Skin lesion; Wound healing

Indexed keywords

ALCHEMILLA VULGARIS EXTRACT; GLYCEROL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALCHEMILLA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CELL COUNT; CELL CULTURE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY EPITHELIUM; LIVER; MALE; MYOFIBROBLAST; NONHUMAN; RAT; SKIN DEFECT; WOUND HEALING;

ALCHEMILLA; ANIMALS; CATTLE; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; FIBROBLASTS; GLYCEROL; HUMANS; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; WOUND HEALING;

ALCHEMILLA VULGARIS; BOVINAE; GLYCERINE; RATTUS;

EID: 34247106298     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2060     Document Type: Article

References (38)

1. Akiyama H, Fujii K, Yamasaki O, Oono T, Iwatsuki K. 2001. Anti-bacterial action of several tannins against Staphylococcus aureus. J Antimicrob Chemother 48: 487-491.
2. Amadeu TP, Coulomb B, Desmouliere A, Costa AM. 2003. Cutaneous wound healing: myofibroblastic differentiation and in vitro models. Int J Low Extrem Wounds 2: 60-68.
3. Ashoori F, Suzuki S, Zhou JH, Isshiki N, Miyachi Y. 1994. Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid. Plast Reconstr Surg 94: 1027-1037.
4. Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. 2006. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg 117(7 Suppl): 72S-109S.
5. Baum CL, Arpey CJ. 2005. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31: 674-686.
6. Desmouliere A. 1995. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 19: 471-476.
7. Dorsett-Martin WA. 2004. Rat models of skin wound healing: a review. Wound Repair Regen 12: 591-599.
8. Filipek J. 1992. The effect of Alchemilla xantochlora water extract on lipid peroxidation and superoxide anion scavenging activity. Pharmazie 47: 717-718.
9. Fraisse D, Carnat A, Carnat AP, Lamaison JL. 1999. Standardization of the aerial parts of Alchemilla. Ann Pharm Fr 57: 401-405.
10. Gabbiani G. 1994. Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis. Pathol Res Pract 190: 851-853.
11. Gomathi K, Gopinath D, Rafiuddin Ahmed M, Jayakumar R. 2003. Quercetin incorporated collagen matrices for dermal wound healing processes in rat. Biomaterials 24: 2767-2672.
12. Gupta A, Kumar R, Pal K, Banerjee PK, Sawhney RC. 2005. A preclinical study of the effects of seabuckthorn (Hippophae rhamnoides L.) leaf extract on cutaneous wound healing in albino rats. Int J Low Extrem Wounds 4: 88-92.
13. Gutierrez-Venegas G, Kawasaki-Cardenas P, Rita Arroyo-Cruz S, Maldonado-Frias S. 2006. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur J Pharmacol 541: 95-105.
14. Heikel H. 1995. Contribution to the Study of Alchemilla vulgaris. D. Pharm. Thesis, Claude Bernard University, Lyon, France, 1-106.
15. Hougee S, Sanders A, Faber J et al. 2005. Decreased proinflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol 69: 241-248.
16. Hunt TK, Hopf H, Hussain Z. 2000. Physiology of wound healing. Adv Skin Wound Care 13(2 Suppl): 6-11.
17. Huttunen M, Harvima IT. 2005. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Br J Dermatol 152: 1149-1160.
18. Jimenez F, Mitts TF, Liu K, Wang Y, Hinek A. 2006. Ellagic and tannic acids protect newly synthesized elastic fibers from premature enzymatic degradation in dermal fibroblast cultures. J Invest Dermatol 126: 1272-1280.
19. Jonadet M, Meunier MT, Villie F, Bastide JP, Lamaison JL. 1986.
20. Flavonoids extracted from Ribes nigrum L. and Alchemilla vulgaris L.: 1. In vitro inhibitory activities on elastase, trypsin and chymotrypsin. 2. Angioprotective activities compared in vivo. J Pharmacol 17: 21-27.
21. Kirsner RS, Eaglstein WH. 1993. The wound healing process. Dermatol Clin 11: 629-640.
22. Lamaison JL, Carnat A, Petitjean-Freytet C. 1990. Tannin content and inhibiting activity of elastase in Rosaceae. Ann Pharm Fr 48: 335-340.
23. Lamaison JL, Carnat A, Petitjean-Freytet C, Carnat AP. 1991. Quercetin-3-glucuronide, main flavonoid of Alchemilla, Alchemilla xanthochlora Rothm. (Rosaceae). Ann Pharm Fr 49: 186-189.
24. Lu HF, Tsou MF, Lin JG et al. 2005. Ellagic acid inhibits growth and arylamine N-acetyltransferase activity and gene expression in Staphylococcus aureus. In Vivo 19: 195-199.
25. Morikawa K, Nonaka M, Narahara M et al. 2003. Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci 74: 709-721.
26. Moulin V, Auger FA, Garrel D, Germain L. 2000. Role of wound healing myofibroblasts on re-epithelialization of human skin. Burns 26: 3-12.
27. Moulin V, Castilloux G, Auger FA, Garrel D, O'Connor-McCourt MD, Germain L. 1998. Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp Cell Res 238: 283-293.
28. Murthy KN, Reddy VK, Veigas JM, Murthy UD. 2004. Study on wound healing activity of Punica granatum peel. J Med Food 7: 256-259.
29. Phan TT, Lee ST, Chan SY, Hughes MA, Cherry GW. 2000. Investigating plant-based medicines for wound healing with the use of cell culture technologies and in vitro models: a review. Ann Acad Med Singapore 29: 27-36.
30. Rotelli AE, Guardia T, Juarez AO, de la Rocha NE, Pelzer LE. 2003. Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 48: 601-606.
31. Shih CM, Lin H, Liang YC, Lee WS, Bi WF, Juan SH. 2004. Concentration-dependent differential effects of quercetin on rat aortic smooth muscle cells. Eur J Pharmacol 496: 41-48.
32. Shrivastava R. 1999. Non-solid composition for local application. Patent PCT/FR/99/01340.
33. Shrivastava R, Chevalier A, Slaoui M, John G. 1993. An in vitro method using vascular smooth muscle cells to study the effect of compounds on cell proliferation and intracellular lipid accumulation. Methods Find Exp Clin Pharmacol 15: 345-350.
34. Singer AJ, Clark RA. 1999. Cutaneous wound healing. N Engl J Med 341: 738-746.
35. Skaper SD, Fabris M, Ferrari V, Dalle Carbonare M, Leon A. 1997. Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med 22: 669-678.
36. Smith JL, Bencivengo MM, Kunsch CA. 1986. Enterotoxin A synthesis in Staphylococcus aureus: inhibition by glycerol and maltose. J Gen Microbiol 132: 3375-3380.
37. Svanberg M, Birkhed D. 1991. Effect of dentifrices containing either xylitol and glycerol or sorbitol on mutans streptococci in saliva. Caries Res 25: 449-453.
38. van Baare J, Ligtvoet EE, Middelkoop E. 1998. Microbiological evaluation of glycerolized cadaveric donor skin. Transplantation 65: 966-970.